20 December ChondroMimetic® Update
19 December Hardman Research: Targeting long-term growth
18 December Collagen Solutions Strengthens Board with Non-Executive Appointment
14 December Appointment of Chief Financial Officer
05 December Half Yearly Report
Interim Results for the six months ended 30 September 2017
26 October Trading Update and Notice of Results
21 September Hardman Research: Engineering towards CE Mark
21 September ChondroMimetic® Study Update
Patient Assessments Completed, Analysis Ongoing
18 September Presenting at the Hardman Investor Forum
12 September Issue of Equity
30 August Result of AGM
30 August AGM Statement
26 July Posting of Annual Report and Notice of AGM
25 July Director/PDMR Dealing
25 July Hardman Research: Transitioning to sustainable growth
13 July Director/PDMR Dealing
11 July Final Results for the year ended 31 March 2017
07 July Collagen Solutions announces first patient enrolment in ChondroMimetic® long-term clinical study
19 June Notice of Results
Analyst briefing
13 June Provisional patent for Bone Graft Substitute formulation submitted
11 May Hardman Research: Trading: earnings above forecasts
25 April Preliminary FY 2017 revenue and other income of £4.1 Million
24 April Consolidation of US R&D activities and Board change
Collagen-Based Spray Adhesive Shows Promising Data for Wound Care Applications
03 April Holding(s) in Company
03 April Agreement signed with Smart Matrix Limited
31 March Holding(s) in Company
29 March Collagen Solutions granted Australian Divisional Patent for Pericardium
27 March Issue of Equity and Director/PDMR Shareholding
24 March Director/PDMR Dealing
23 March UK Investor Show 2017 attendance
20 March Collagen Solutions introduces new online sales initiative in the US
15 March Holding(s) in Company
14 March Holding(s) in Company
13 March Holding(s) in Company
13 March Hardman Research: Engineering cartilage repairs
09 March Holding(s) in Company
09 March Holding(s) in Company
09 March Collagen Solutions attends AAOS and ORS Meetings in San Diego
Support for Brain Awareness Week 13-19 March
08 March Grant of Options
07 March Holding(s) in Company
07 March Director/PDMR Dealing
07 March Holding(s) in Company
07 March Holding(s) in Company
06 March Result of General Meeting and Open Offer
20 February Investor Presentation
15 February Grant of Options
14 February Norgine Ventures completes £4 million financing with Collagen Solutions (Press Release)
14 February Hardman Research: Funding accelerated growth
14 February Conditional Placing and Open Offer to raise up to £8.0 million
Conditional issue of up to £4.0 million in senior secured private bonds with warrants
and Notice of General Meeting
07 February Collagen Solutions at the Medical Design and Manufacturing West Conference in Anaheim 7-9 February
19 January Team Strengthened with New Scientific Advisory Board Appointments
13 January Awarded third Medical Research Scotland Ph.D. Studentship